Investing.com - Biodesix (NASDAQ: BDSX) reported third quarter EPS of $-0.070, in line with the analyst estimate of $-0.070. Revenue for the quarter came in at $18.2M versus the consensus estimate of $18.57M.
Biodesix's stock price closed at $1.70. It is up 4.940% in the last 3 months and up 14.860% in the last 12 months.
Biodesix saw positive EPS revisions and negative EPS revisions in the last 90 days. See Biodesix's stock price’s past reactions to earnings here.
According to InvestingPro, Biodesix's Financial Health score is "fair performance".
Check out Biodesix's recent earnings performance, and Biodesix's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar